Page last updated: 2024-09-03

sr 33557 and trimipramine

sr 33557 has been researched along with trimipramine in 1 studies

Compound Research Comparison

Studies (sr 33557)	Trials (sr 33557)	Recent Studies (post-2010) (sr 33557)	Studies (trimipramine)	Trials (trimipramine)	Recent Studies (post-2010) (trimipramine)
50	3	1	367	86	40

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bordier, C; Chen, KG; Durán, GE; Jaffrézou, JP; Laurent, G; Levade, T; Muller, C; Sikic, BI	1

Other Studies

1 other study(ies) available for sr 33557 and trimipramine

Article	Year
Inhibition of lysosomal acid sphingomyelinase by agents which reverse multidrug resistance. Biochimica et biophysica acta, 1995, 04-06, Volume: 1266, Issue:1 Topics: Affinity Labels; Animals; Desipramine; Doxorubicin; Drug Interactions; Drug Resistance, Multiple; Indolizines; Leukemia P388; Lysosomes; Mianserin; Mice; Phenethylamines; Rhodamine 123; Rhodamines; Sphingomyelin Phosphodiesterase; Trimipramine; Tumor Cells, Cultured; Vasodilator Agents; Vinblastine	1995

Article

Year

Inhibition of lysosomal acid sphingomyelinase by agents which reverse multidrug resistance.

Biochimica et biophysica acta, 1995, 04-06, Volume: 1266, Issue:1

Topics: Affinity Labels; Animals; Desipramine; Doxorubicin; Drug Interactions; Drug Resistance, Multiple; Indolizines; Leukemia P388; Lysosomes; Mianserin; Mice; Phenethylamines; Rhodamine 123; Rhodamines; Sphingomyelin Phosphodiesterase; Trimipramine; Tumor Cells, Cultured; Vasodilator Agents; Vinblastine

1995